Company data
Maze Therapeutics, Inc. employees and revenue per employee
MAZE · Biotechnology · $1.50B market cap
Maze Therapeutics, Inc. had 125 employees at the end of fiscal Dec 2024. Revenue for the year was $168M, or $1.34M per employee.
Employees
125
Revenue
$168M
Revenue / employee
$1.34M
Peer median $459K
Rank in industry
24 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
Maze Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | 125 | $168M | $1.34M | — |
| STOK Stoke Therapeutics, Inc. | 170 | $184M | $1.08M | Efficient growth |
| SNDX Syndax Pharmaceuticals, Inc. | 298 | $172M | $578K | Efficient growth |
| PHAT Phathom Pharmaceuticals, Inc. | 371 | $175M | $472K | Leaner |
| RGNX REGENXBIO Inc. | 371 | $170M | $459K | Efficient growth |
| RYTM Rhythm Pharmaceuticals, Inc. | 414 | $190M | $458K | Hiring ahead |
| MRVI Maravai LifeSciences Holdings, Inc. | 435 | $186M | $427K | Contracting |
| DNA Ginkgo Bioworks Holdings, Inc. | 485 | $170M | $351K | Contracting |
| BEAM Beam Therapeutics Inc. | 511 | $140M | $273K | Efficient growth |
Questions about Maze Therapeutics, Inc.
- How many employees does Maze Therapeutics, Inc. have?
- Maze Therapeutics, Inc. reported 125 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 31, 2025.
- What is Maze Therapeutics, Inc.'s revenue per employee?
- Maze Therapeutics, Inc. brought in $168M of revenue in fiscal Dec 2024, which is $1.34M per employee. That ranks 24 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare MAZE with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Maze Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 31, 2025. This is data, not a recommendation to buy or sell MAZE.